Source: BEFREE ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs104894846
rs104894846
0.710 GeneticVariation BEFREE The white blood cell α-gal activity was very low, and genetic analysis revealed a GLA gene variant (M296I), which is known as a late-onset genetic mutation of FD. 31847900

2019

dbSNP: rs28935494
rs28935494
0.810 GeneticVariation BEFREE This case also provides the first clinical evidence that the p.G360R mutation is pathogenic and responsible for a classic phenotype of Fabry disease. 31634893

2020

dbSNP: rs148158093
rs148158093
0.760 GeneticVariation BEFREE This is the first report that shows a link between FD renal Gb3 deposits and c.352C>T/p.Arg118Cys variant, supporting pathogenicity of a variant considered until now with uncertain pathogenicity. 31566927

2019

dbSNP: rs869312142
rs869312142
0.830 GeneticVariation BEFREE A founder effect of FD due to p.F113L mutation was documented by genealogy and genetics in a Portuguese region. 31519519

2020

dbSNP: rs104894828
rs104894828
0.840 GeneticVariation BEFREE Hemizygous mutations associated with Fabry disease were detected in two male patients (2.50% of the screened population): NM_000169.2:c.334C>T(p.Arg112Cys), NM_000169.2:c.902G>A(p.Arg301Gln). 31446751

2019

dbSNP: rs104894834
rs104894834
0.830 GeneticVariation BEFREE Hemizygous mutations associated with Fabry disease were detected in two male patients (2.50% of the screened population): NM_000169.2:c.334C>T(p.Arg112Cys), NM_000169.2:c.902G>A(p.Arg301Gln). 31446751

2019

dbSNP: rs869312142
rs869312142
0.830 GeneticVariation BEFREE The α-galactosidase gene (GLA) c.337T>C/p.Phe113Leu variant was originally described in patients with late-onset cardiac forms of Fabry disease (FD), who had residual α-galactosidase activity. 31200018

2020

dbSNP: rs869312265
rs869312265
0.010 GeneticVariation BEFREE Our study reveals the pathogenesis of splicing mutation c.801 + 1G > A to FD and provides scientific foundation for accurate diagnosis and precise medical intervention for FD. 30853972

2019

dbSNP: rs28935490
rs28935490
0.780 GeneticVariation BEFREE This suggests that p.D313Y causes a potentially treatable condition resembling an early stage of Fabry disease. 30830284

2019

dbSNP: rs886041315
rs886041315
0.710 GeneticVariation BEFREE Computational and modeling approaches to understand the impact of the Fabry's disease causing mutation (D92Y) on the interaction with pharmacological chaperone 1-deoxygalactonojirimycin (DGJ). 30635085

2019

dbSNP: rs148158093
rs148158093
0.760 GeneticVariation BEFREE A single patient had a possible pathogenic variant, R118C, in the GLA gene, but clinical investigation showed no firm signs of FD. 30246259

2019

dbSNP: rs104894833
rs104894833
0.800 GeneticVariation BEFREE The genetic analysis did not identify a causative mutation responsible for classic Fabry disease in any of the patients, but 2 patients (.4%) carried the p.E66Q in GLA. 30201457

2018

dbSNP: rs869312386
rs869312386
0.710 GeneticVariation BEFREE Generation of the human induced pluripotent stem cell line (UKWNLi001-A) from skin fibroblasts of a woman with Fabry disease carrying the X-chromosomal heterozygous c.708 G > C (W236C) missense mutation in exon 5 of the alpha-galactosidase-A gene. 30130681

2018

dbSNP: rs28935197
rs28935197
0.860 GeneticVariation BEFREE This case report details a discordant phenotype in brothers with Fabry disease and p.N215S mutation. 30023289

2018

dbSNP: rs104894845
rs104894845
0.860 GeneticVariation BEFREE The p.A143T variant is a genetic variant of unknown significance, with its associated phenotype ranging from classical FD to healthy unaffected patients. 29867742

2018

dbSNP: rs28935197
rs28935197
0.860 GeneticVariation BEFREE To expand on the scarce phenotype data, we analyzed natural history data from 125 p.N215S patients (66 females, 59 males) enrolled in the Fabry Registry (NCT00196742) and compared it with data from 401 patients (237 females, 164 males) harboring mutations associated with classic Fabry disease. 29649853

2018

dbSNP: rs104894845
rs104894845
0.860 GeneticVariation BEFREE Additionally, we detected 8 subjects carrying genetic variants possibly linked to late onset Fabry disease (p.Arg118Cys and p.Ala143Thr), 4 cases with polymorphism p.Asp313Tyr and 36 individuals with single nucleotide polymorphisms in intronic regions of GLA. 29631605

2018

dbSNP: rs28935490
rs28935490
0.780 GeneticVariation BEFREE Additionally, we detected 8 subjects carrying genetic variants possibly linked to late onset Fabry disease (p.Arg118Cys and p.Ala143Thr), 4 cases with polymorphism p.Asp313Tyr and 36 individuals with single nucleotide polymorphisms in intronic regions of GLA. 29631605

2018

dbSNP: rs148158093
rs148158093
0.760 GeneticVariation BEFREE Additionally, we detected 8 subjects carrying genetic variants possibly linked to late onset Fabry disease (p.Arg118Cys and p.Ala143Thr), 4 cases with polymorphism p.Asp313Tyr and 36 individuals with single nucleotide polymorphisms in intronic regions of GLA. 29631605

2018

dbSNP: rs28935197
rs28935197
0.860 GeneticVariation BEFREE Taken together, cardiac variant N215S mutation is rather an attenuated form of classical FD. 29294190

2018

dbSNP: rs28935490
rs28935490
0.780 GeneticVariation BEFREE Our findings indicate that the D313Y variant is not causative to nor enhancing Fabry disease phenotype. 29037082

2017

dbSNP: rs28935197
rs28935197
0.860 GeneticVariation BEFREE α-Galactosidase A genotype N215S does not lead to the development of a classical Fabry phenotype but induces a specific cardiac variant of Fabry disease mimicking nonobstructive hypertrophic cardiomyopathy. 29018006

2017

dbSNP: rs28935490
rs28935490
0.780 GeneticVariation BEFREE Eight D313Y carriers were presenting signs of FD despite not fulfilling the criteria of the disease, two had no FD signs and two others were apparently healthy. 28988177

2017

dbSNP: rs398123226
rs398123226
0.710 GeneticVariation BEFREE Clinical assessments, α-galactosidase A (α-GalA) activities, glycosphingolipid substrate levels, and in vitro mutation expression were used to categorize p.D322E as a classic FD mutation and p.I232T as a later-onset FD mutation. 28798024

2017

dbSNP: rs28935197
rs28935197
0.860 GeneticVariation BEFREE Abnormalities in lipid rafts (LRs) were observed in fibroblasts isolated from a male patient with FD bearing the mutation N215S. 28351893

2017